Navigation Links
Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Date:10/23/2007

of TPI 287 in resistant tumors and the progress of TPI 287 in clinical trials. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward- looking statements. Such risks, uncertainties and other factors include risks that clinical trials for TPI 287 will be delayed due to institutional approvals, patient recruitment, formulation and manufacturing difficulties, delays in finalizing and receiving approval of protocols, negotiations with regulatory agencies, or other factors; that human clinical trials may show that TPI 287 is unsafe and/or ineffective in treating cancer in humans. General implementation risks associated with development of TPI 287 include those that we are blocked or limited in the development of TPI 287 because of the intellectual property rights of third parties; that we are limited in our ability to obtain, maintain and enforce our own intellectual property; that development of TPI 287 is delayed or terminated because the costs of further development exceed its value; and that the Company's resources will be insufficient to continue development. Additional risks, uncertainties and other factors are identified under the captions "Risk Factors" and "Special Note Regarding Forward-Looking Statements" in the Company's reports filed from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q for the periods ended March 28, 2007, and June 27, 2007. The Company cautions investors not to place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update publicly or revise any forward-looking statements, whether as a result of new or additional information, future events or otherwise.

Contact: Tapestry Pharmaceuticals, Inc.

Gordon Link


'/>"/>

SOURCE Tapestry Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007 AACR Annual Meeting
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. , (OTCQB: DMPI), developer of ... presenting company at the 16th Annual Rodman & Renshaw ... & Co., LLC. The presentation will take place Tuesday, September ... Salon (4th floor) at the New York Palace Hotel ...
(Date:8/27/2014)... 2014 Reportlinker.com announces that a new ... Global Orthopedic Soft Tissue Repair Devices ... About Orthopedic Soft Tissue Repair ... cells that connect, support, or surround bones. There ... as tendons, ligaments, cartilage, fascia, and other fibrous ...
(Date:8/27/2014)... LOS ANGELES , Aug. 27, 2014   ... , now offers AcceleDent® Aura to patients who want ... to orthodontic care available at the OrthoSpaceship, all patients ... healthier, better-looking teeth. This system can be used by ... boost their rate of progress by using the AcceleDent® ...
Breaking Medicine Technology:DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2
... Several abstracts highlighting CIMZIA,s long-term benefits and value ... American College,of Gastroenterology (ACG), ORLANDO, Fla. Oct. ... by UCB at the American College of Gastroenterology,(ACG) ... the,only PEGylated anti-TNF alpha (Tumor Necrosis Factor alpha) ...
... Ardea Biosciences, Inc.,(Nasdaq: RDEA ) announced ... Highly Selective MEK1/2 Inhibitor is Beneficial in Dextran ... was presented at the,American College of Gastroenterology (ACG) ... provided data from a preclinical study of,RDEA119, the ...
Cached Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4
(Date:8/27/2014)... When it comes to the bedroom, most homeowners ... without breaking the bank in the process. Regardless of whether ... set for the master bedroom or simply looking for something ... all during their Labor Day mattress promotion. , This ... mattresses for the home, while enjoying free delivery. Beyond bringing ...
(Date:8/27/2014)... Taking its popular obstacle race to a new ... will host its largest crowd at its 3rd Annual ... YMCA Camp Thunderbird . , Hundreds of ... and teams. Within each division, runners will attempt to conquer ... for a worthy cause. All proceeds will fund scholarships ...
(Date:8/27/2014)... August 28, 2014 All Canada Goose ... they can go from classic to modern. With unique detailing ... each of them is a step up in opulence. Recently, ... Goose Banff Parkas for 2014. , True enough, ... now offering great discounts (up to 28% off) on all ...
(Date:8/27/2014)... The New York Mobility Club (sponsored by ... about “ Sexuality & Intimacy ” for people with ... entertaining discussions are for mature audiences only. September 9 ... Mamaroneck, NY) and October 7 from 6-8 pm at ... The New York Mobility Club is a local community ...
(Date:8/27/2014)... 2014 Recently, iFitDress.com, a professional company ... new designs of romantic bridal gowns . To ... promotional price (up to 66 percent off) when buying ... product line has been updated with these new items. ... iFitDress.com hopes that all clients can gain an enjoyable ...
Breaking Medicine News(10 mins):Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Promotion For Romantic Bridal Gowns Launched By Professional Company iFitDress.com 2
... , CINCINNATI, Dec. 8, ... PG ) today announced the appointment of Angela ... WellPoint, Inc. (NYSE: WLP ), to its ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20091208/CL22979-a ) ...
... is open for the 2010 AIUM Annual Convention and ... United States dedicated to all disciplines of medical ultrasound, ... California. The 2010 Annual Convention focuses on emerging applications ... and manufacturers as ultrasound continues to advance and expand ...
... 7, 2009Scientists at The Scripps Research Institute have determined the ... though rare, is one of the deadliest viruses on the ... Described in the advance, online Early Edition of the journal ... PNAS ), the research reveals how a key component of ...
... say , TUESDAY, Dec. 8 (HealthDay News) -- The human ... study shows how the twisting and turning differs between men ... published in the Dec. 8 online edition of Circulation: ... different heartbeats they saw in 29 men and 29 women, ...
... Over two-thirds of study patients benefited from high-flow oxygen ... High-flow oxygen appears to be an effective treatment for ... cluster headaches can have as many as eight per ... The current treatment is injection with the drug sumatriptan, ...
... male sex hormone causes status-seeking behavior, but not aggression, ... People associate testosterone with aggressiveness, but the male sex ... new study finds. , Testosterone does not cause aggression, ... economics at Royal Holloway, University of London. But it ...
Cached Medicine News:Health News:Procter & Gamble Announces Appointment of Director 2Health News:AIUM gears up for 2010 Annual Convention in San Diego, California 2Health News:Scripps Research scientists reveal key structure from ebola virus 2Health News:Beating Heart Differs by Gender, Age: Study 2Health News:Oxygen Therapy May Relieve Cluster Headache Pain 2Health News:Testosterone Gets Bad Rap: Study 2Health News:Testosterone Gets Bad Rap: Study 3
... laparoscopic procedures, the Advantage Smart Table goes ... tables but is versatile enough to accommodate ... remote, this table remembers positions for various ... multi-articulation or return to level. The simple ...
... complete imaging access, with nearly 100 percent ... imaging C-Arms can pan from head to ... patient. Anesthesiologists will appreciate this table for ... construction, and ease of operation. The key ...
Inquire...
...
Medicine Products: